Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (325)

clinicaltrialsPublishedShowing 51–100 of 131 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07392957	Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma	recruiting	Phase 1 / Phase 2	54	Washington University School of MedicineOTHER	1	Jun 22, 2026	clinicaltrials
NCT07541781	Sitagliptin in Recurrent/Progressive Grade 4 Glioma	recruiting	Phase 1	45	Kailin Yang, MD, PhDOTHER	1	Jun 17, 2026	clinicaltrials